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In the central nervous system, two subtypes of sodium- and chloride-coupled GABA transporter xist. One is sensitive to ACHC, the other to 
~.alanine. They are thought o be of neuronal and $1iai origin, reslZ:ctively. GABA transport in membrane v~icles derived from asttoglial ceils 
was found to be sodium- and chloride-dependent, lectroganic and much more sensitive to fl-alanine than to ACHC. Immunobloning with 
antibodies dir~ted against a variety of sequenc,s of the ACHC-sensitive transporter indicated that none of these pitopes was shared by the glial 
transporter. 
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1. INTRODUCTION 
High-affinity, sodium-dependent neurotransmitter 
uptake is thought to be the mechanism by which the 
overall process of synaptic transmission is terminated 
[1-3]. GABA is the major inhibitory transmitter in the 
central nervous system. Its high-affinity uptake system 
co-transports GABA with sodium and chloride [4,5]. In 
rat brain there are at least two different transporters. 
One - GABAA - is inhibited by ACHC, while the other 
- GABAa - is sensitive to fl-alanine [6]. They are 
thought to be of neuronal [7,8] and glint origin [9], re- 
spectively. 
One of the GABA transporters has been purified [10] 
and was subsequently cloned [11]. This transporter is 
sensitive xclusively to ACHC [6,12] and thus is proba. 
bly of neuronal origin. This is reinforced by immunocy- 
tochemical localization studies employing an antibody 
raised against the pure transporter [l 3]. 
At the present ime it is not clear if GABAA and 
GABAa transporters are two forms of the same protein 
- for instance phosphorylated and dephosphorylated - 
or two distinct proteins. Therefore we have studied 
GABA transport in membranes derived from astroglial 
cells and have employed sequence-directed antibodies 
against the GABAA transporter to answer the above 
question. 
Correspondence address: B.I. Kanner, Department of Biochemistry, 
Hadassah Medical School, The Hebrew University, PO Box 1172, 
Jerusalem, Israel. Fax: (972) (2) 784010. 
Abbreviation#: GABA, 7-aminr~butyric a id; ACHC, cL~-3-aminocy- 
¢lohesane earboxylie aoid; GFAP, 81ial fibrillary acid protein. 
2. MATERIALS AND METHODS 
2.1. Materials 
[~H]GABA (47.6 Ci/mmol) was obtained from the Nuclear R~arch 
Center, Negev. [mIlProtein A (30 mCi/m$) was from Amersham. 
Reagents for tissue culture, including Dulbecmo minimal essential 
medium, MEM HEPES, and fetal calf serum were from C.dbeo/BRL. 
ACHe was synthesized for u¢ by Erwin Gross, from the Pilot Plant 
at the School for Applied Science of the Hebrew University, according 
to the method of Johnston et al. [14]. Valinomycin and fluorochrome- 
labelled secondary antibodies were from Sigma; ni~ricin from C.al- 
biochem. Monoclonal antibodies against GFAP were purc~ from 
BoehHng~r. Antisera gainst synthetic peptides corresponding to the 
aminoterminas (Psls:; residues 6-19); residue 410--422 (P4ta4~) or 
residues 480--493 (P4t~-~9~) of the neuronal GABA transporter mole- 
cule were generated in rabbits as previously described [15"]. 
Antiserum against the carboxy terminal as well as its corresponding 
peptide (Pcooa; residues 571-586) were a generous #It from Dr. 
Reinhard Jahn (Yale University Medical School, New Haven, C'T). 
The antibody against the intact ransporter was prepared as described 
[10]. All antibodies were purified by binding to Affi-g*l 15 (Bio-Rad) 
carrying the partially purified transporter as described [13]. 
2.2. Cell culture 
Primary cultures of mouse cortical astro~tes were obtained from 
two-day-old BALB/c mioe essentially as described [16]. Cells were 
grown on poly-n-lysine (50 ms/l) -coated 250 ml culture flasks at 37~C 
in a moist atmosphere containing 5% CO~. Cultures were fed twic~ a 
w~k with Dulbeceo minimal essential medium (high glucose formula- 
tion) supplemented with 10% fetal calf serum, 2 mM glutamiae, 2.4 
g/l sodium bicarbonate and 100 m$/I $entamycin. For immunofluo- 
resent staining, glial precurt~r cells were shaken off mcchanimlly 
from the surface of the monolayer and subcultured in 35-ram petri 
dishes in the presence of 10% ~¢~am to promote differentiation into 
type 2 estroqaes. 
2.3. Preparation of astroglial nwmbrane ve#icle# 
After three weeks in culture cells were washed with 0.32 M mannitol 
and I mM Na-EDTA, pH 7.4, and harvested with a rubber policeman. 
Subsequently they were homogenized on ice in 0.1 M sodium phos- 
phate buffer containing 1% glycerol, 1 mM M8SO4, 0.5 mM EDTA 
and 5 mM TRl$.s~fa~, pH 7.4 (homogenization buffer) and ~¢n- 
trifuged for 10 rain at 3,000 x g to remove nuclei and undisrupted cells. 
The supernatant was centrifuged for 20 rain at 27,000 x g at 4°C. The 
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Fig. 1. Ion-dependence and effects of ionophores on GABA transport, Transport of GABA was measured for the indi¢ated times, using astroglial 
membrane vesicles at 100 pg of protein per time point. In each mixtur~ (approx, 190 pl) 1 #Ci of [~h~GABA was present (i.e. 0,1/zM GABA). 
(A) The composition of the external medium was 0.15 M NaCl (A), 0.15 choline chloride (r~) or 0.15 M sodium isethionatc (o). (B) The external 
media contained 0.15 M NaCI in the presence of one of the following ioaophores: none (A), 5/zM nigericin (a) or 2.5 ~uM valinomycin (A). 
resulting pellet was suspended and diluted in 5 mM TRIS.HCI and ! 
mM Na-£DTA, pH 7.4, After the osmotic shock, the membranes were 
collected by centrifuging at 27,000 x g for 20 rain, The pellet was 
resuspended in homogenization buffer, divided into aliquots and 
froz¢n in liquid n!trogen. 
2.4. Preparatiot~ of #ynapto#omal embrane v sicles 
Crude synnptosomal membrane vesicles were prepared from rat or 
mouse brain as described [4], 
2.5. Transport 
Membrane vesioles were thawed rapidly at 37°C, loaded with 0.1 
M KPi, pH 6.9 and assayed for GABA transport as described [4]. Time 
points wcr¢ done in triplicate. Standard deviations were 2-4%. There- 
fore, only mean values are indicated. 
2.6. lmmunoflu,~rescenc¢ 
Cultures were fixed in ethanol/acetic a id (5:1, v/v) for 10 rain at 
-20°C. After several washes with MEM-HEPES and MEM-HI~PES 
containing I% bovine serum albumin, cells were sequentially in. 
oubated for 30 rain at room temperature with antibodies against a 
peptide fragment of the neuronal GABA transporter mol¢cule (diluted 
1:100 in MEM.BSA) and with a monoclonal anti-OFAP antibody 
(diluted 1:20), After four washes in MEM th¢ s0condary antibody 
mixture (FITC-conjugated goat anti-mouse IgO and TRITe-con. 
jugated goat anti-rabbit IgG, both diluted 1:50 in MEM-BSA) was 
added for 30 rain, After rinsin~ in MEM-HEPES,  preparations wer~ 
mounted in gelvatol and examined in an Olympus IMT2 inverted 
microsoft, 
2,7. Other methods 
SDS-PAGE [17] was done with 4% stacking el and 10% separating 
gel, exactly as described [10]. Analysis of the specificity of the antibod- 
ies was done ¢sscntially as described [10,18], Protein determination 
was done according to the Bradford method [19]. 
3. RESULTS AND DISCUSSION 
When membrane vesicles derived from astroglial cells 
were loaded with potassium phosphate and diluted into 
a NaCl-containing medium, accumulation of 
[3H]GABA was observed (Fig. IA). In the absence of 
either external sodium or chloride, uptake was abol- 
ished (Fig. IA). The potassium-specific ionophor¢, vali- 
nomycin, is expected, under these conditions, to en- 
hance the membrane potential (interior negative). Addi- 
tion of this ionophore stimulates uptake by about 25% 
(Fig. 1 B), indicating that the process is electrogenic. The 
exchange ionophor¢, nigericin, is expected to exchange 
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Fig, 2, Inhibition of [~HIGABA transport by substrate analogues. (A) GABA transport ates were measured for 4 rain using astroglial membrane 
v~icles at 100/~$ of protein per time point. (B and C) GABA transport at~ were measured for 2 min using crude synaptosomal membrane v sicles 
from mouse or rat brain, respcc:!vely, at 200/zg ofprotein per time point. In each reaction 1/zCi of[3HIGABA was present, Substrate analogues 
were present in the influx medium (0.15 M NaCi) only at the indicated concentration, except in the case where ,$-alanine and ACHC were added 
together. There it reflects the to~l concentration, consisting of an identical contribution from each, A, ACHe; n,,8-alanine; o,ACHe and,fl-alanine 
together. 100% transport was 0,88, 75.6 or 19.6 pmol/min.mg protein in A, B or C, roslxmtively. 
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Fig. 3. Double.labeling mmunostaining of cultured astroey, te.s from mouse brain using monoclonal anti.GFAP antibodies (A) in conjunction witr, 
anti-P~2 antibodi,s (B). S¢a1¢ bars indicate 26.7 am. 
~,xternal sodium and internal potassium, thereby col- 
lapsing the sodium gradient and probably also the 
membrane potential. It can be observed that nigericin 
causes a time-dependent inhibition of [~I-I]GABA 
uptake (Fig. 1B). This GABA transport in glial 
membrane vesicles is in many aspects reminiscent of 
that in membranes from ratbrain [4]. The sodium, and 
chloride-dependence of the process in astroglial 
membranes can actually be predicted from previous 
observations that if~ membrane vesicles from rat brain, 
where both subtypes are expressed [6], no GABA 
uptake at all was observed in the absence of either 
sodimn or chloride [4,6]. Also, membrane vesicles from 
rat brain exhibited a single high-affinity K~ for GABA 
(2-3 ItM), similar to that of the isolated GABAA 
transporter [4,10]. Thus, a similar value is expected for 
the GABAB transporter. Indeed, a Km of about 2/tM 
was observed in the glial membrane vesicles. The value 
of V,~x was 20-30 pmol/min.mg protein. 
The data presented in Fig. 2 indicate that the glial 
GABA transporter xhibits the pharmacological profile 
expect.ed for the OABAB transporter. Thus, p.alanin¢ 
was a much more potent inhibitor than ACHC in the 
glial membrane vesicles (Fig. 2A). On the other hand, 
both compounds inhibited GABA transport in mem- 
brane vesicles from either mouse or rat brain and their 
101 
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Fig, 4, Immunorcactivity of membrane vesicles towards different anti- 
bodies. Membrane vesicles from rat brain (lanes a), mouse brain (lanes 
b) or cultured astroglial mils (lanes e) were subjected to SDS-PAGE 
and immunoblotted with thefollowing antibodies: I, antibody against 
the whole GABAA transporter; II, anti-PNN., antibody; 1II, anti-P4~_,~ 
antibody; and IV, anti-PcooH antibody. 40 #g of membrane protein 
were loaded per each lane of a and b, and 450/.~g for that ore lanes, 
inhibition was additive (Fig. 2B and C). No such additi- 
vity was observed in glial membrane vesicles (Fig. 2A). 
Thus, the glial membranes feature only one transporter, 
namely the OABAD subtype. 
3.1. Double-labeling immunostahzing of cultured astro- 
cytes 
Further evidence for molecular differences between 
the neuronal and the glial GABA transporter was 
gained from double-labeling immunostaining of cul- 
tured ~strocytes as shown in Fig. 3. The antibody 
against GFAP, a specific molecular marker for 
astrocytes, tains nearly all of the stellate-shaped cells 
in the culture. However, the anti-P4to_4.~2 antibody of'~he 
GABAA transporter does not stain any of these cells. 
The same was true for anti-PNH: or anti-P4s0_~0~antibod- 
ies (data not shown). The only cells which light up are 
GFAP-negative cglls with an oligodendrocyte morphol- 
ogy occasionally occuring in the culture. It should be 
noted, however, in this context, that oligodendrocytes 
previously were suggested to have a neuronal-like 
GABA uptake system [20]. 
Fig. 4 shows immunoblotting data with several se- 
quence-directed antibodies against various parts of the 
(}ABAA transporter as well as with one raised against 
the whole transporter. When membrane vesicles from 
both rat and mouse brain were probed with these anti- 
bodies a b~.nd of around 80 kDa lit up (Fig. 4, lanes a 
and b). This agrees with the well-known mobility of the 
pure GABAA transporter [10,15]. On the other hand, 
the glial membrane did not react with any of the anti- 
bodies (Fig. 4, lanes c), notwithstanding the fact that the 
amount of GABA transport activity loaded on the gel 
was the same for all types of membranes. Thus, out of 
a variety of epitopes present in the GABAA transporter, 
none is shared by its GABAn counterpart. I  is therefore 
concluded that the two are distinct proteins. However, 
this does not exclude (possible) homologous sequences, 
e.g. in the transmembrane domains. As neurotrans- 
mitter transporters appear to belong to a novel super- 
family [21-25], it should be possible to clone the 
GABAB transporter with a PCR-type of approach. 
Comparison of eDNA clones encoding for the two 
GABA transporters with those encoding for other 
members of the family may indicate features uch as the 
structural basis of the GABA binding site. 
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